These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30635607)

  • 21. The fold preference and thermodynamic stability of α-synuclein fibrils is encoded in the non-amyloid-β component region.
    Xu L; Bhattacharya S; Thompson D
    Phys Chem Chem Phys; 2018 Feb; 20(6):4502-4512. PubMed ID: 29372732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baicalein exhibits differential effects and mechanisms towards disruption of α-synuclein fibrils with different polymorphs.
    Yao Y; Tang Y; Zhou Y; Yang Z; Wei G
    Int J Biol Macromol; 2022 Nov; 220():316-325. PubMed ID: 35981677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.
    Bickle L; Hopwood JJ; Karageorgos L
    Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):261-273. PubMed ID: 28007442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of polyols on the structure and aggregation of recombinant human γ-Synuclein, an intrinsically disordered protein.
    Roy S; Bhat R
    Biochim Biophys Acta Proteins Proteom; 2018 Oct; 1866(10):1029-1042. PubMed ID: 30003969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils.
    Bodles AM; Guthrie DJ; Harriott P; Campbell P; Irvine GB
    Eur J Biochem; 2000 Apr; 267(8):2186-94. PubMed ID: 10759841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid fibrils prepared using an acetylated and methyl amidated peptide model of the α-Synuclein NAC 71-82 amino acid stretch contain an additional cross-β structure also found in prion proteins.
    Näsström T; Andersson PO; Lejon C; Karlsson BCG
    Sci Rep; 2019 Nov; 9(1):15949. PubMed ID: 31685848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oleuropein aglycone stabilizes the monomeric α-synuclein and favours the growth of non-toxic aggregates.
    Palazzi L; Bruzzone E; Bisello G; Leri M; Stefani M; Bucciantini M; Polverino de Laureto P
    Sci Rep; 2018 May; 8(1):8337. PubMed ID: 29844450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational investigation on the effect of Oleuropein aglycone on the α-synuclein aggregation.
    Borah P; Sanjeev A; Mattaparthi VSK
    J Biomol Struct Dyn; 2021 Mar; 39(4):1259-1270. PubMed ID: 32041489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.
    Cohlberg JA; Li J; Uversky VN; Fink AL
    Biochemistry; 2002 Feb; 41(5):1502-11. PubMed ID: 11814343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient β-hairpin formation in α-synuclein monomer revealed by coarse-grained molecular dynamics simulation.
    Yu H; Han W; Ma W; Schulten K
    J Chem Phys; 2015 Dec; 143(24):243142. PubMed ID: 26723627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One ring is sufficient to inhibit α-synuclein aggregation.
    Pena-DIaz S; Ventura S
    Neural Regen Res; 2022 Mar; 17(3):508-511. PubMed ID: 34380879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
    Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The aggregation and fibrillation of alpha-synuclein.
    Fink AL
    Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
    Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
    J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes.
    Munishkina LA; Phelan C; Uversky VN; Fink AL
    Biochemistry; 2003 Mar; 42(9):2720-30. PubMed ID: 12614167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Huang W; Liu J; Le S; Yao M; Shi Y; Yan J
    APL Bioeng; 2024 Mar; 8(1):016114. PubMed ID: 38435467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
    Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
    J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.